EcoActive(Intralytix)(EcoActive(Intralytix)) - 在研适应症：克罗恩病_专利_临床

概要

基本信息

药物类型

噬菌体疗法

别名-

靶点-

作用机制

细菌替代物

治疗领域

免疫系统疾病消化系统疾病

在研适应症

克罗恩病

非在研适应症-

原研机构

Intralytix, Inc.

在研机构

Intralytix, Inc.

非在研机构-

最高研发阶段临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 EcoActive(Intralytix) 相关的临床试验

NCT03808103 / Recruiting临床1/2期

A Phase 1/2a Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Oral Administration of EcoActive on Intestinal Adherent Invasive Escherichia Coli (AIEC) in Patients With Inactive Crohn's Disease (CD)

This study will evaluate the safety of oral administration of EcoActive to patients with inactive Crohn's disease and how it affects the levels of AIEC in stool.

开始日期2019-05-01

申办/合作机构

Intralytix, Inc.

[+2]

NCT00945087 / Unknown statusN/AIIT

Experimental Phage Therapy of Drug-resistant Bacterial Infections, Including MRSA Infections

The primary purpose of this experimental therapy is to treat, with the aid of bacteriophages, patients with non-healing postoperative wounds or bone, upper respiratory tract, genital or urinary tract infections in whom extensive antibiotic therapy failed or the use of the targeted drug is contraindicated.

开始日期2005-12-01

申办/合作机构-

100 项与 EcoActive(Intralytix) 相关的临床结果

登录后查看更多信息

100 项与 EcoActive(Intralytix) 相关的转化医学

登录后查看更多信息

100 项与 EcoActive(Intralytix) 相关的专利（医药）

登录后查看更多信息

100 项与 EcoActive(Intralytix) 相关的药物交易

登录后查看更多信息